The Th1/Th2 dichotomy, hsp60 autoimmunity, and type I diabetes.

This paper presents some questions and issues regarding the concept of the Th1/Th2 dichotomy and summarizes results using an hsp60 peptide to treat the spontaneous autoimmune process of diabetes in NOD mice.

[1]  I. Cohen,et al.  Autoimmune disease models : a guidebook , 1994 .

[2]  C. Parish.  Immune deviation: A historical perspective * , 1996, Immunology and cell biology.

[3]  I. Cohen,et al.  NOD mouse diabetes: the ubiquitous mouse hsp60 is a beta-cell target antigen of autoimmune T cells. , 1996, Journal of autoimmunity.

[4]  M Eisenstein,et al.  Molecular characterization of the diabetes-associated mouse MHC class II protein, I-Ag7. , 1997, International immunology.

[5]  C. Snapper,et al.  Transforming growth factor beta 1 selectivity stimulates immunoglobulin G2b secretion by lipopolysaccharide-activated murine B cells , 1993, The Journal of experimental medicine.

[6]  C. Snapper,et al.  Towards a comprehensive view of immunoglobulin class switching. , 1993, Immunology today.

[7]  I. Cohen,et al.  A role of Hsp60 in autoimmune diabetes: analysis in a transgenic model. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[8]  G. Nepom,et al.  Allele-specific motifs characterize HLA-DQ interactions with a diabetes-associated peptide derived from glutamic acid decarboxylase. , 1996, Journal of immunology.

[9]  I. Cohen,et al.  Suppressive vaccination with DNA encoding a variable region gene of the T–cell receptor prevents autoimmune encephalomyelitis and activates Th2 immunity , 1996, Nature Medicine.

[10]  Irun R. Cohen,et al.  Islet T Cells Secreting IFN-γ in NOD Mouse Diabetes: Arrest by p277 Peptide Treatment , 1998 .

[11]  John A Todd,et al.  Genetic Analysis of Autoimmune Disease , 1996, Cell.

[12]  B. Roep.  T-Cell Responses to Autoantigens in IDDM: The Search for the Holy Grail , 1996, Diabetes.

[13]  I. Cohen,et al.  Induction of diabetes in standard mice by immunization with the p277 peptide of a 60‐kDa heat shock protein , 1995, European journal of immunology.

[14]  I. Cohen,et al.  The hsp60 Peptide p277 Arrests the Autoimmune Diabetes Induced by the Toxin Streptozotocin , 1996, Diabetes.

[15]  I. Cohen,et al.  Peptide therapy for diabetes in NOD mice , 1994, The Lancet.

[16]  I. Cohen.  Treatment of autoimmune disease: to activate or to deactivate? , 1995, Chemical immunology.

[17]  J. Bach.  Insulin-dependent diabetes mellitus. , 1991, Current opinion in immunology.

[18]  I. Cohen,et al.  Thymus-Derived Lymphocytes: Humoral and Cellular Reactions Distinguished by Hydrocortisone , 1972, Science.

[19]  K. HayGlass,et al.  A simple, sensitive, dual mAb based ELISA for murine gamma interferon determination: comparison with two common bioassays. , 1993, Journal of immunoassay.

[20]  R. Coffman,et al.  TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. , 1989, Annual review of immunology.

[21]  I. Cohen.  The cognitive paradigm and the immunological homunculus. , 1992, Immunology today.

[22]  I. Cohen,et al.  Treatment of Autoimmune Diabetes and Insulitis in NOD Mice With Heat Shock Protein 60 Peptide p277 , 1995, Diabetes.

[23]  I. Cohen,et al.  Autoimmune Diabetes Induced by the β-cell Toxin STZ: Immunity to the 60-kDa Heat Shock Protein and to Insulin , 1994, Diabetes.

[24]  Irun R Cohen,et al.  Hsp60 Peptide Therapy of NOD Mouse Diabetes Induces a Th2 Cytokine Burst and Downregulates Autoimmunity to Various β-Cell Antigens , 1997, Diabetes.

[25]  I. Cohen,et al.  Vaccination against autoimmune mouse diabetes with a T-cell epitope of the human 65-kDa heat shock protein. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[26]  I. Cohen,et al.  Induction and therapy of autoimmune diabetes in the non-obese diabetic (NOD/Lt) mouse by a 65-kDa heat shock protein. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[27]  D. Elias.  The NOD Mouse: A Model for Autoimmune Insulin-Dependent Diabetes , 1994 .